Automated cell counters are instruments that help identify and count cells in a sample. They are used in applications such as disease diagnosis, stem cell research, and drug discovery among others. Automated cell counters provide reliable cell counts in a short span of time and help analyze multiple samples simultaneously. They also eliminate errors caused by manual counting. The growing focus on evaluating cell behaviour and treatment response for various diseases has boosted the demand for automated cell counters.
The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Growing Adoption in R&D Activities
The market is witnessing significant growth opportunities owing to increasing adoption of automated cell counters in research and development activities. Cell counting plays a vital role in various R&D procedures such as stem cell research, drug discovery, and toxicity testing. Automated cell counters help researchers analyze large number of cell samples and gain insightful data in less time. This is encouraging various pharmaceutical and biotechnology companies as well as academic research institutes to incorporate automated cell counters in their facilities. With rising investments in cell-based research, the adoption of automated cell counters is expected to surge substantially over the forecast period. This will present lucrative opportunities for players in the global automated cell counters market.
Porter's Analysis
Threat of new entrants: Low-moderate due to the requirement of substantial capital investments and technical expertise. However, threat may increase with rising opportunities.
Bargaining power of buyers: Moderate-high due to the availability of substitutes and price sensitivity of buyers. Larger customers have more bargaining power.
Bargaining power of suppliers: Moderate due to the availability of substitutes and dominance of few major suppliers. Suppliers have bargaining power regarding pricing and quality.
Threat of new substitutes: Moderate as new technologies like flow cytometry offer substitutes but automated cell counters still have advantage in fields like hematology.
Competitive rivalry: High due to several global players offering differentiated products and continuous technological advancements.
SWOT Analysis
Strengths: Growing healthcare expenditure, rising demand for personalized medicine, growing applications in stem cell research and drug discovery.
Weaknesses: High costs of instruments, lack of skilled professionals, stringent regulations.
Opportunities: Emerging markets growth, increasing R&D investments, growing focus on single cell analysis, development of lab-on-chip technologies.
Threats: Threat from substitutes, pricing pressures from buyers, reimbursement issues.
Key Takeaways
The global automated cell counters market is expected to witness high growth during the forecast period. The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
North America dominates the market currently due to presence of major players, growing biotechnology industry and healthcare expenditure. Asia Pacific is expected to grow at the fastest pace due to growing healthcare infrastructure, favorable policies and rising healthcare expenditure. Key regional factors fueling growth include growing biotechnology industry, increasing stem cell research activities, supportive government initiatives. Countries like China, India, South Korea and Japan are expected to offer lucrative opportunities.
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. The players are focusing on new product launches, mergers and acquisitions to strengthen their market presence.
